SCHEMBL28698376

SCHEMBL28698376

Cc1ccc(-c2cc(C(=O)Nc3ncc(-c4ccco4)[nH]3)c3ccccc3n2)o1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 13/20 0.61
▸ ALDH1A1 P00352 12/20 0.61
▸ KDM4E B2RXH2 10/20 0.61
▸ L3MBTL1 Q9Y468 10/20 0.61
▸ HPGD P15428 9/20 0.61
▸ MEN1 O00255 9/20 0.61
▸ KMT2A Q03164 9/20 0.61
▸ PKM P14618 8/20 0.61
▸ MAPT P10636 8/20 0.61
▸ CTDSP1 Q9GZU7 6/20 0.61
▸ TSHR P16473 5/20 0.61
▸ HSD17B10 Q99714 5/20 0.61
▸ ALOX12 P18054 5/20 0.61
▸ LMNA P02545 5/20 0.61
▸ ALOX15 P16050 4/20 0.61
▸ CASP1 P29466 2/20 0.61
▸ CASP7 P55210 2/20 0.61
▸ TDP1 Q9NUW8 5/20 0.60
▸ MCL1 Q07820 4/20 0.60
▸ HTT P42858 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28699093 0.91 CTDSP1 (0.62) POLBALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL28681436 0.87 STAT3 (0.61) POLBALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL28683183 0.87 CHEK1 (0.58) POLBALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL28672562 0.84 CHEK1 (0.60) POLBALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL28695985 0.84 STAT3 (0.55) POLBALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL28693620 0.84 STAT3 (0.52) POLBALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL28693080 0.84 STAT3 (0.64) POLBALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL28683191 0.83 MEN1 (0.54) POLBALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL28699068 0.83 STAT3 (0.54) POLBALDH1A1KDM4EL3MBTL1HPGD
SCHEMBL28679478 0.83 ALDH1A1 (0.53) POLBALDH1A1KDM4EL3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113747920-A Immune checkpoint inhibitor combination therapy using quinoline carboxamide derivatives 株式会社益力多本社 2021-12-03 — — CN disclosed
CN-112703001-A Combination cancer therapy using quinoline carboxamide derivatives 株式会社益力多本社 2021-04-23 — — CN disclosed
Send feedback